Imatinib reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukaemia.

Autor: Simsek, Eda Tanrikulu, Eskazan, Ahmet Emre, Cengiz, Mahir, Cem Ar, Muhlis, Ekizoglu, Seda, Salihoglu, Ayse, Gulturk, Emine, Elverdi, Tugrul, Aydin, Seniz Ongoren, Demiroz, Ahu Senem, Buyru, Ayse Nur, Baslar, Zafer, Ozbek, Ugur, Ferhanoglu, Burhan, Aydin, Yildiz, Tuzuner, Nukhet, Soysal, Teoman
Předmět:
Zdroj: Journal of Clinical Pathology; Sep2016, Vol. 69 Issue 9, p810-816, 7p, 1 Color Photograph, 5 Charts, 2 Graphs
Databáze: Complementary Index